Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Published on by Infectious

Prof. Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Professor | Badji-Mokhtar University | Algeria

Prof. Amel Bouzabata is a distinguished researcher and academic at Université Badji Mokhtar – Annaba, Algeria, recognized for her expertise in analytical chemistry, phytochemistry, and antioxidant studies. She obtained her Ph.D. in Analytical Chemistry from the same university in 2014, where she developed an early interest in the metabolic profiling of natural compounds and the bioactive evaluation of medicinal plants. Over the years, Prof. Bouzabata has built a strong academic and research portfolio focused on natural product analysis, chromatographic techniques, and high-resolution mass spectrometry (HR-LC-ESI-Orbitrap-MS). Her professional experience includes teaching undergraduate and postgraduate chemistry courses, supervising graduate theses, and participating in interdisciplinary research projects that link chemistry with pharmacology and environmental science. She has collaborated with international researchers to explore the biochemical diversity of regional flora, contributing to several peer-reviewed publications in Scopus-indexed and Q1 journals such as Antioxidants and Journal of Natural Products. Her research interests extend to metabolomics, chemometric analysis, and the discovery of novel antioxidant and antimicrobial compounds from natural sources. Prof. Bouzabata’s research skills include advanced chromatographic separation, spectral interpretation, multivariate data analysis, and the use of bioassay-guided fractionation for compound identification. She has received institutional recognition for her scientific contributions and is actively involved in promoting research capacity development among young scientists in Algeria. Through mentorship and collaboration, she has strengthened the university’s research visibility and global academic partnerships. Prof. Bouzabata continues to pursue innovative approaches to natural compound characterization, integrating analytical precision with biological relevance to address emerging scientific and health challenges. Her dedication to high-quality research and international collaboration underscores her growing influence in chemical and biological sciences. Prof. Amel Bouzabata has achieved 420 total citations across 15 published research documents, demonstrating a consistent scholarly impact with an h-index of 11, based on 376 citing documents in Scopus.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Bouzabata, A., Montoro, P., Gil, K. A., Piacente, S., et al. (2022). HR-LC-ESI-Orbitrap-MS-Based metabolic profiling coupled with chemometrics for the discrimination of different Echinops spinosus organs and evaluation of their antioxidant activity.

2. Bouzabata, A. (2015). Contribution à l’étude d’une plante médicinale et aromatique Myrtus communis L. Faculté de Médecine, Université Badji-Mokhtar, Annaba, Algérie.

3. Bouzabata, A., Bighelli, A., Abed, L., Casanova, J., & Tomi, F. (2014). Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Natural Product Communications, 9(5), 1934578X1400900530.

4. Bouzabata, A., & Yavuz, M. (2019). Médecine traditionnelle et ethnopharmacologie en Algérie: de l’histoire à la modernité. Ethnopharmacologia.

5. Bouzabata, A., & Boukhari, A. (2014). Variation in the traditional knowledge of Curcuma longa L. in North-Eastern Algeria. International Journal of Biological, Veterinary, Agricultural and Food Engineering.

 

Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Researcher | Academic Center for Education, Culture and Research | Iran

Dr. Sanaz Ahmadi Ghezeldasht is a distinguished researcher and molecular biologist at the Molecular Biology Section, Central Laboratory ACECR, Mashhad, Iran, specializing in medical immunology, molecular virology, and infectious diseases. She holds a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences, an M.Sc. in Animal Physiology from Payam-e-Noor University of Isfahan, and a B.Sc. in Biology from Ferdowsi University of Mashhad. Dr. Ghezeldasht has served as the Supervisor of the Molecular Biology Center at Jahad Daneshgahi Mashhad, contributing to several national and international research projects focused on HTLV-1 pathogenesis, viral immunology, and host-virus interactions. Her prolific research portfolio encompasses numerous peer-reviewed publications in high-impact journals such as Reviews in Medical Virology, Journal of NeuroVirology, and Applied Biochemistry and Biotechnology, highlighting novel insights into viral oncogenesis, molecular diagnostics, and therapeutic development. A dedicated academic leader, she has organized and contributed to multiple scientific congresses and health monitoring initiatives. Dr. Ghezeldasht’s expertise extends to genetic engineering, bioinformatics, PCR technologies, and cell culture, complemented by certifications in English proficiency and advanced computer literacy. She is an active member of the HTLV-I Foundation and the Research Center for HIV/AIDS, HTLV, and Viral Hepatitis at ACECR, reflecting her enduring commitment to advancing molecular medicine and public health. Her scholarly impact is reflected by 409 citations across 26 publications with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publication

1. Shafaei, A., Talebi, K., Zarean, M., Mosavat, A., Khajedaluee, A. R., Afzalaghaee, M., Shamsian, S. A. A., & Ghezeldasht, S. A. (2025). Intestinal parasitic infections, eosinophilia, and Th1/Th2 immune profiles in haemodialysis patients. Parasite Immunology.

2. Rahimzada, M., Nahavandi, M., Saffari, M., Shafaei, A., Mosavat, A., Ghezeldasht, S. A., Ariaee, N., Valizadeh, N., Rahimi, H., Rezaee, S. A., et al. (2023). Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL). Molecular Biology Reports, 50(9).

3. Yousefpoor, N., Mahdavian, M., Pourbagher, Z., Ghezeldasht, S. A., Mosavat, A., Ziaee, M., Bahreini, M., Soleimanpour, S., Sharifmoghadam, M. R., Valizadeh, N., et al. (2023). Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region. Microbial Pathogenesis, 180, 106170.

4. Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 29(4), 567–578.